can you switch from semaglutide to tirzepatide Switching Tirzepatide: What Need to Know Switching Between Semaglutide and Tirzepatide:

Contact your GP or diabetes specialist if you experience : Persistent vomiting that prevents you from keeping down food, fluids, or other medications for more than 24 hours Signs of dehydration , including dark urine, dizziness, extreme thirst, dry mouth, or reduced urination Abdominal pain , particularly if constant, sharp, or radiating to your back (potential pancreatitis) Nausea that significantly worsens rather than improves over time Inability to maintain adequate nutrition or unintended weight loss exceeding clinical targets Symptoms of hypoglycaemia (low blood sugar) if taking Ozempic alongside insulin or sulphonylureasshakiness, confusion, sweating, rapid heartbeat [1] [4] Right upper abdominal pain, fever, or yellowing of skin/eyes , which could indicate gallbladder disease (a known risk with GLP-1 receptor agonists) Seek immediate medical attention (call 999 or attend A&E) if you develop : Severe, persistent abdominal pain with vomiting (possible pancreatitis) Signs of allergic reactionfacial swelling, difficulty breathing, severe rash Symptoms of diabetic ketoacidosisexcessive thirst, frequent urination, confusion, fruity-smelling breath (particularly relevant if you use insulin or during intercurrent illness

There should be not be clinical evidence of non-syncope conditions including seizures, hypoglycemia, drug or alcohol intoxication, concussion due to head trauma and so forth

Semaglutide is the active ingredient in several diabetes and weight loss drugs like Ozempic, Wegoby, and Rybelsus

HR = hazard ratio

In total, 100 participants with T2D who have been treated with liraglutide (0.91.8 mg/day in plan A) or dulaglutide (0.75 mg/week in plan B) for more than 12 weeks and have a glycated hemoglobin (HbA1c) level of 6.09.9% and a body mass index (BMI) of 22 kg/m 2 will be randomized to either continue using their existing GLP-1 receptor agonist or switch to subcutaneous semaglutide once weekly for 24 weeks

The frequency of gastrointestinal side effects may affect the drug continuation rate